Promising new therapeutic option for HIV - next generation HIV-1 investigational protease cleavage site (maturation) inhibitor, HRF-10071

Conference Reports for NATAP

IAS 2025, 13th IAS Conference on HIV Science
Kigali, Rwanda
July 13-17


Promising new therapeutic option for HIV - next generation HIV-1 investigational protease cleavage site (maturation) inhibitor, HRF-10071 - phase 2 results

	IAS 2025 ( N. KUMARASAMY )